Biochemically Recurrent Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 1(2)
Frequently asked questions
How many drugs are in development for Biochemically Recurrent Prostate Cancer?
BioSniper tracks 2 drugs in development for Biochemically Recurrent Prostate Cancer across 2 companies.
How many clinical trials target Biochemically Recurrent Prostate Cancer?
There are 2 clinical trials targeting Biochemically Recurrent Prostate Cancer tracked by BioSniper.
What is the prevalence of Biochemically Recurrent Prostate Cancer?
The estimated prevalence of Biochemically Recurrent Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Biochemically Recurrent Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis